HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.020
+0.020 (1.00%)
At close: Aug 7, 2026, 4:00 PM EDT
1.996
-0.024 (-1.17%)
After-hours: Aug 7, 2026, 7:15 PM EDT
HeartSciences Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HeartSciences stock has a consensus rating of "Buy" and an average price target of $10. The average 1-year stock price forecast is 395.05% higher than the current stock price, while the lowest is $8.00 (+296.04%) and the highest is $12 (+494.06%).
Price Target: $10 (+395.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HeartSciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Dec '25 | Mar '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $12 | Buy | Reiterates | $12 | +494.06% | Jul 30, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $8 | Buy | Maintains | $8 | +296.04% | Mar 23, 2026 |
Financial Forecast
Revenue This Year
15.00K
from 4.32K
Increased by 247.30%
Revenue Next Year
3.15M
from 15.00K
Increased by 20,900.00%
EPS This Year
-2.62
from -3.48
EPS Next Year
-1.86
from -2.62
EPS and Forward PE are based on non-GAAP adjusted numbers.